Dr. Isidro Benjamin Salusky, MD

Dr. Salusky practices at DaVita Century City Dialysis in Los Angeles, California.

Dr. Salusky's NPI, 1861501546, was assigned on August 29, 2006. Dr. Salusky graduated from University of Buenos Aires in 1971. Dr. Salusky's California license number on file is A40549.

Dr. Salusky's primary practice is DaVita Century City Dialysis, at 10630 Santa Monica Boulevard, Los Angeles, CA 90025 in Los Angeles County. The practice phone is (310) 954-2700.

Dr. Salusky's primary practice is DaVita Century City Dialysis in Los Angeles, California. Dr. Salusky is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Health. Dmand AI also links Dr. Salusky to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Salusky practices, 3 sites in all. Vendor and product names are available with a free account.

Pediatric nephrology is Dr. Salusky's primary specialty in the NPI Registry, under taxonomy code 2080P0210X. Dr. Salusky is board certified in pediatric nephrology by the American Board of Pediatrics. Dr. Salusky has a license on file in California.

CMS data shows 12 Medicare services from Dr. Salusky across 1 procedure code in 2024, all of them office visits, for 25 Medicare patients. Medicare paid $786 for them. Every service was in an office.

CMS counts 25 Medicare patients who saw Dr. Salusky in 2024. The largest group is under 65, with 14 patients. 68% of them have high blood pressure, and 60% have high cholesterol. Their average risk score is 4.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Salusky's median patient age at 18, with 43% women.

In 2024, Dr. Salusky wrote 21 Medicare Part D claims. 57% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $756 in total drug cost. In 2020, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 78 out of 100 for Dr. Salusky for performance year 2024, reported as part of a group. Dr. Salusky accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 54 papers to Dr. Salusky, published from 2003 to 2025. 2012 was the busiest year, with 6. The most frequent topics are Calcium, Renal Insufficiency, Chronic and Bone Diseases, Metabolic. Dr. Salusky's most frequent co-authors are Marciana Lee Laster, MD, Myles Selig Wolf, MD and Michelle Denburg, MD.

Dmand AI links Dr. Salusky to 3 clinical trials, 2 of them phase 2 studies. Conditions studied include Chronic Kidney Disease-Mineral and Bone Disorder and Rickets.

CMS Open Payments shows 109 general payments to Dr. Salusky from 14 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 52% of the total. Ultragenyx Pharmaceutical Inc. paid the most, $52,548.

Dmand AI lists 3 awards for Dr. Salusky, most recently Top Doctors:LA Area in 2013.

Dr. Salusky graduated from University of Buenos Aires in 1971.

Dr. Salusky is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.